DTL
EBS icon

Dynamic Technology Lab’s Emergent Biosolutions EBS Stock Holding History

Dynamic Technology Lab’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-96,758
Closed -$232K – 1141
2023
Q4 		$232K Buy
+96,758
New +$227K 0.02% 839
2022
Q2 		– Sell
-10,410
Closed -$427K – 1237
2022
Q1 		$427K Buy
+10,410
New +$459K 0.05% 648
2021
Q4 		– Sell
-11,410
Closed -$571K – 1214
2021
Q3 		$571K Buy
+11,410
New +$691K 0.07% 474
2020
Q2 		– Sell
-4,196
Closed -$243K – 1060
2020
Q1 		$243K Buy
+4,196
New +$242K 0.05% 678
2018
Q1 		– Sell
-5,465
Closed -$254K – 1116
2017
Q4 		$254K Buy
+5,465
New +$230K 0.05% 781
2016
Q3 		– Sell
-21,028
Closed -$591K – 944
2016
Q2 		$591K Buy
+21,028
New +$824K 0.16% 188

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dynamic Technology Lab's EBS Position: Q1 2024 in Review

Dynamic Technology Lab sold out of Emergent Biosolutions (EBS) in Q1 2024, closing a stake of 96,758 shares — an estimated $232K sold.

Dynamic Technology Lab first reported a position in EBS in Q2 2016 and held it in 6 quarters. The position peaked at $591K in Q2 2016. 122 funds tracked by Wall St. Rank hold EBS as of Q1 2024.

  • Dynamic Technology Lab reported no remaining Emergent Biosolutions position as of Q1 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 96,758 Emergent Biosolutions shares in Q1 2024, an estimated $232K.
  • Dynamic Technology Lab first reported a position in Emergent Biosolutions in Q2 2016 and held it in 6 quarters.
  • Dynamic Technology Lab's Emergent Biosolutions position peaked at $591K in Q2 2016.
  • 122 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2024.

Based on Dynamic Technology Lab's 13F filing for Q1 2024, filed 14 May 2024.